Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Renata Slowik
Simultaneous CXCL12 and ESR1 CpG Island Hypermethylation Correlates With Poor Prognosis in Sporadic Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
MAPT Promoter CpG Island Hypermethylation Is Associated With Poor Prognosis in Patients With Stage II Colorectal Cancer
Cancer Management and Research
Oncology
Epigenetic Inactivation of EGFR by CpG Island Hypermethylation in Cancer
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Hypermethylation of MEG3 Promoter Correlates With Inactivation of MEG3 and Poor Prognosis in Patients With Retinoblastoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
CpG Island Hypermethylation ofBRCA1and Loss of pRb as Co-Occurring Events in Basal/Triple-Negative Breast Cancer
Epigenetics
Cancer Research
Medicine
Molecular Biology
The Suppression of DUSP5 Expression Correlates With Paclitaxel Resistance and Poor Prognosis in Basal-Like Breast Cancer
International Journal of Medical Sciences
Medicine
GATA5 CpG Island Hypermethylation Is an Independent Predictor for Poor Clinical Outcome in Renal Cell Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Flotillin2 Expression Correlates With HER2 Levels and Poor Prognosis in Gastric Cancer
PLoS ONE
Multidisciplinary
CpG Island Methylator Phenotype and Prognosis of Colorectal Cancer in Northeast China
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics